The Catalan Institute of Nanoscience and Nanotechnology (ICN2) is a non-profit research foundation, and one of the centres of the CERCA Institution. Its mission is to achieve scientific and technological excellence in the fields of nanotechnology and nanoscience. ICN2’s excellence has been recognized by the Spanish Government with the award of the prestigious Severo Ochoa Centre of Excellence accreditation (2014-2018, 2018-2022).
ICN2 is mostly involved in WP1 (“Technology of neural interfaces”), where it is in charge of developing the technology of ultra-flexible µECoG arrays using graphene field-effect transistors and the multiplexing technology using MoS2 ultra-thin films. ICN2 also contributes to WP3 (“Preclinical assessment of novel implants and bottom-up identification of decoding capacity of functional cortical dynamics”), providing support to the in-vitro and in-vivo assessment of the developed implant technology. ICN2 is also contributing with its expertise in MOCVD, in particular to upscale the current growth capability of TMDs (MoS2) to 4 inch wafers. Further, ICN2 coordinates the BrainCom project (J.A. Garrido is the project coordinator).
INBRAIN Neuroelectronics is a spin off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) dedicated to the development of neuroelectronic therapies through graphene-based, high-resolution neural interfaces, with unprecedented stimulating and recording capabilities for the treatment of neurological disorders.
Our research has become an icon of the Graphene Flagship, where our scientific team leads the biomedical technologies work packages. INBRAIN owns the rights to a joint basic patent application between ICN2 and the University of Manchester (National Graphene Institute, headed by Nobel Prize winners Geim and Novoselov). Now we want to bring this technology to the market and become the world’s reference neuroelectronic interface company to treat brain related disorders.
The INBRAIN team combines experts leading the EU GRAPHENE flagship with executives from leading medical device companies.
IMEC – Imec is a world-leading research and innovation hub in nanoelectronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure (state-of-the-art cleanrooms and labs) and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, energy and education. As a trusted partner for companies, start-ups and universities we bring together more than 5,000 brilliant minds from over 97 nationalities. IMEC is headquartered in Leuven, Belgium and has distributed R&D groups at a number of Flemish universities, in the Netherlands and the USA, and offices in China, India and Japan. IMEC is one of four Strategic Research Centers in Flanders/Belgium. In 2020, imec’s revenue (P&L) totaled 680 million euro.
Fraunhofer IZM specializes in industry-oriented applied research. Fraunhofer IZM develops assembly and interconnection technology, also known as electronic packaging. Almost invisible and undervalued by many, electronic packaging is at the heart of every electronic application. Our technologies connect the individual components, protect components and devices from vibration and moisture, and reliably dissipate heat. Fraunhofer IZM thus ensures that electronic devices continue to function reliably in even the harshest conditions. Modern packaging technologies make developing smaller and smaller products possible. We process ICs thinner than a sheet of paper. The institute, founded in 1993, has a staff of more than 400 and disposes of a lab area of over 8,000 sqm. About 80 percent of our turnover in 2021 was earned through contract research.
ETH Zurich – Institute of Robotics and Intelligent Systems – The Multi-Scale Robotics Lab (MSRL) pursues a dynamic research program that maintains a strong robotics research focus on several emerging areas of science and technology. A major component of the MSRL research leverages advanced robotics for creating intelligent machines that operate at micron and nanometer scales. MSRL research develops the tools and processes required to fabricate and assemble micron sized robots and nanometer scale robotic components. Many of these systems are used for robotic exploration within biomedical and biological domains.
Nanoflex Robotics AG is a Swiss start-up and a spinoff from ETHZ. We have developed a soft robotic system that uses small electromagnetic fields to precisely maneuver specially made devices (guidewires and catheters) deep into the brain. These novel devices are softer, more manoeuvrable, able to follow multiple curves trajectories, and easier to use than anything currently available. The technology can simplify and shorten procedure time when accessing the brain.
ICN2 – el coordinador del proyecto (la descripción con el logo los podrías coger de la web que te enseñe).
“The Catalan Institute of Nanoscience and Nanotechnology (ICN2) is a non-profit research foundation, and one of the centres of the CERCA Institution. Its mission is to achieve scientific and technological excellence in the fields of nanotechnology and nanoscience. ICN2’s excellence has been recognized by the Spanish Government with the award of the prestigious Severo Ochoa Centre of Excellence accreditation (2014-2018, 2018-2022).
ICN2 is mostly involved in WP1 (“Technology of neural interfaces”), where it is in charge of developing the technology of ultra-flexible µECoG arrays using graphene field-effect transistors and the multiplexing technology using MoS2 ultra-thin films. ICN2 also contributes to WP3 (“Preclinical assessment of novel implants and bottom-up identification of decoding capacity of functional cortical dynamics”), providing support to the in-vitro and in-vivo assessment of the developed implant technology. ICN2 is also contributing with its expertise in MOCVD, in particular to upscale the current growth capability of TMDs (MoS2) to 4 inch wafers. Further, ICN2 coordinates the BrainCom project (J.A. Garrido is the project coordinator).”
INBRAIN Neuroelectronics is a spin off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) dedicated to the development of neuroelectronic therapies through graphene-based, high-resolution neural interfaces, with unprecedented stimulating and recording capabilities for the treatment of neurological disorders.
Our research has become an icon of the Graphene Flagship, where our scientific team leads the biomedical technologies work packages. INBRAIN owns the rights to a joint basic patent application between ICN2 and the University of Manchester (National Graphene Institute, headed by Nobel Prize winners Geim and Novoselov). Now we want to bring this technology to the market and become the world’s reference neuroelectronic interface company to treat brain related disorders.
The INBRAIN team combines experts leading the EU GRAPHENE flagship with executives from leading medical device companies.
IMEC – Imec is a world-leading research and innovation hub in nanoelectronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure (state-of-the-art cleanrooms and labs) and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, energy and education. As a trusted partner for companies, start-ups and universities we bring together more than 5,000 brilliant minds from over 97 nationalities. IMEC is headquartered in Leuven, Belgium and has distributed R&D groups at a number of Flemish universities, in the Netherlands and the USA, and offices in China, India and Japan. IMEC is one of four Strategic Research Centers in Flanders/Belgium. In 2020, imec’s revenue (P&L) totaled 680 million euro.
Fraunhofer IZM specializes in industry-oriented applied research. Fraunhofer IZM develops assembly and interconnection technology, also known as electronic packaging. Almost invisible and undervalued by many, electronic packaging is at the heart of every electronic application. Our technologies connect the individual components, protect components and devices from vibration and moisture, and reliably dissipate heat. Fraunhofer IZM thus ensures that electronic devices continue to function reliably in even the harshest conditions. Modern packaging technologies make developing smaller and smaller products possible. We process ICs thinner than a sheet of paper. The institute, founded in 1993, has a staff of more than 400 and disposes of a lab area of over 8,000 sqm. About 80 percent of our turnover in 2021 was earned through contract research.
ETH Zurich – Institute of Robotics and Intelligent Systems – The Multi-Scale Robotics Lab (MSRL) pursues a dynamic research program that maintains a strong robotics research focus on several emerging areas of science and technology. A major component of the MSRL research leverages advanced robotics for creating intelligent machines that operate at micron and nanometer scales. MSRL research develops the tools and processes required to fabricate and assemble micron sized robots and nanometer scale robotic components. Many of these systems are used for robotic exploration within biomedical and biological domains.
Nanoflex Robotics AG is a Swiss start-up and a spinoff from ETHZ. We have developed a soft robotic system that uses small electromagnetic fields to precisely maneuver specially made devices (guidewires and catheters) deep into the brain. These novel devices are softer, more manoeuvrable, able to follow multiple curves trajectories, and easier to use than anything currently available. The technology can simplify and shorten procedure time when accessing the brain.
Leiden University Medical Center (LUMC) – As a center of medical innovation the Leiden University Medical Center (LUMC) seeks to play an (inter)nationally recognized prominent role in improving the quality of health care. Its core tasks are research, education, patient care, training and continuing education. LUMC is part of the Dutch Federation of University Medical Centers (NFU), the alliance of the eight university medical centers in the Netherlands. The LUMC believes in curing but also in prevention. By calling in companies and organisations in and outside the region, the LUMC makes innovations and new applications actually possible. Thus the LUMC wishes to play a leading role in the development of solutions to healthcare questions. ‘The LUMC as an innovator stands for improving healthcare and people’s health’.
As a center of medical innovation the Leiden University Medical Center (LUMC) seeks to play an (inter)nationally recognized prominent role in improving the quality of health care. Our core tasks are research, education, patient care, training and continuing education. LUMC is part of the Dutch Federation of University Medical Centers (NFU), the alliance of the eight university medical centers in the Netherlands.
The Czech Advanced Technology and Research Institute (CATRIN) commits to the development of new technologies for clean energy and sustainable environment, thus promoting health and well-being of the society. CATRIN of Palacký University Olomouc aims to become a leading European research institute. Our mission is to carry out interdisciplinary research into emerging nanotechnologies, biotechnologies and biomedicine at the highest international level, alongside their further advancement and application.
